Skip to main content

Advertisement

Advancing nanoparticles from the bench to the bedside: logistical issues

Interaction with man-made nanoparticles is becoming inescapable in the daily lives of people around the world. This has been enabled by the explosion of research in nanotechnology especially in medicinal and consumer products. This research has catalyzed the design of products with precisely engineered and highly robust functionalities with minimal toxicity. The next step is to advance these exciting new discoveries from the bench to the bedside. Here, there seems to be a bottleneck where very few nanotechnology products have successfully transitioned. Even among those that have moved to clinical testing, many have failed to demonstrate clear clinical benefit. This collection in Cancer Nanotechnology seeks to highlight strategies to overcome potential regulatory, societal, business and legal hurdles. 

Topics include, but are not limited to: 

  • Challenges with scale-up and reproducibility
  • Defining the regulatory path to clinical testing
  • Legal and intellectual property issues
  • Trends in business practice
  • Government and regulatory science 

Edited by:
Steven Curley, Christus Trinity Mother Frances, Texas, USA
Sunil Krishnan, MD Anderson, Texas, USA
Željka Krpetić, University of Salford, UK

Submission deadline:
30 September 2019

Submission Instructions
Before submitting your manuscript, please ensure you have carefully read the submission guidelines for Cancer Nanotechnology. The complete manuscript should be submitted through the Cancer Nanotechnology submission system. To ensure that you submit to the correct thematic series please select the appropriate thematic series in the drop-down menu upon submission. In addition, indicate within your cover letter that you wish your manuscript to be considered as part of the collection (thematic series) on "Advancing nanoparticles from the bench to the bedside: logistical issues". All submissions will undergo rigorous peer review and accepted articles will be published within the journal as a collection.

Submissions will also benefit from the usual advantages of open access publication:

  • Rapid publication: Online submission, electronic peer review and production make the process of publishing your article simple and efficient.
  • High visibility and international readership in your field: Open access publication ensures high visibility and maximum exposure for your work - anyone with online access can read your article
  • No space constraints: Publishing online means unlimited space for figures, extensive data and video footage
  • Authors retain copyright, licensing the article under a Creative Commons license: articles can be freely redistributed and reused as long as the article is correctly attributed.

Sign up to article alerts to keep updated on articles published in Cancer Nanotechnology - including articles published in this collection!

Advertisement